Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 14, 2025; 31(10): 102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Endoscopic treatment outcome of oesophageal gastrointestinal stromal tumours
En-Pan Xu, Zhi-Peng Qi, Bing Li, Zhong Ren, Ming-Yan Cai, Shi-Lun Cai, Zhen-Tao Lv, Zhang-Han Chen, Jing-Yi Liu, Yun-Shi Zhong, Qiang Shi, Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
En-Pan Xu, Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo 315000, Zhejiang Province, China
Jia-Wei Zhang, Endoscopy Center, Shanghai Xuhui District Central Hospital, Shanghai 200030, China
Ping-Hong Zhou, Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Co-first authors: En-Pan Xu and Zhi-Peng Qi.
Author contributions: Shi Q, Zhong YS, and Zhou PH designed the research study; Xu EP, Qi ZP, Zhang JW, Li B, Ren Z, Cai MY, Cai SL, Lv ZT, Chen ZH, Liu JY, Zhong YS, and Zhou PH performed the research; All authors have read and approve the final manuscript.
Supported by National Natural Science Foundation of China, No. 82002515, No. 82273025 and No. 82203460; China Postdoctoral Science Foundation, No. 2022TQ0070 and No. 2022M710759; and Shanghai Municipal Commission of Science and Technology, No. 22JC1403003, No. 22XD1402200, No. 19140901902 and No. 22S31903800.
Institutional review board statement: The Committee of Medical Ethics (Zhongshan Hospital Fudan University, No. B2020-265R) approved this study.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The data that support the findings of this study are available from the corresponding author, upon reasonable request at shi.qiang@zs-hospital.sh.cn.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Qiang Shi, MD, Associate Chief Physician, Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai 200032, China. shi.qiang@zs-hospital.sh.cn
Received: October 16, 2024
Revised: January 4, 2025
Accepted: February 8, 2025
Published online: March 14, 2025
Processing time: 132 Days and 19.6 Hours
Revised: January 4, 2025
Accepted: February 8, 2025
Published online: March 14, 2025
Processing time: 132 Days and 19.6 Hours
Core Tip
Core Tip: Oesophageal gastrointestinal stromal tumours are extremely rare. Endoscopic resection proves to be both safe and effective for patients with low-risk. Early detection plays a critical role in determining the prognosis of these tumours.